Related by context. All words. (Click for frequent words.) 50 DuraHeart 48 Destination Therapy 46 Randomized Evaluation 45 Phase III HEAT 45 Estracure 44 fosbretabulin 44 Delcath PHP System 44 StemEx 44 Levacor VAD 44 NCCTG 44 Novacor LVAS 44 Levacor 43 prospective multicenter 43 Levacor TM 43 volociximab 43 Augment Injectable 43 everolimus eluting stent 43 Augment Injectable Bone Graft 43 TAXUS ATLAS 43 SEPET TM 43 IFN alpha 2a 43 APEX PD 43 Phase Ib clinical 43 Imprime PGG 43 RE MODEL 43 FlowCardia 43 multicenter randomized controlled 43 Transplant BTT 42 GEM OS1 42 Phase IIb III 42 VAD 42 Ventricular Assist Device VAD 42 multicenter prospective 42 phase IIa clinical 42 MIST II 42 BioSTAR ® 42 transfemoral 42 octreotide 42 ZYBRESTAT TM 42 Phase Ib IIa clinical 42 BrachySil ™ 42 RELIANT trial 42 Lung Rx 42 AdnaGen 42 CIMZIA TM 42 STARFlex ® 41 Tryton 41 tinzaparin 41 DuraHeart TM 41 TAXUS V 41 PDL# 41 Indaflex TM 41 iSONEP 41 phase IIb clinical 41 IN.PACT 41 TURBO Booster 41 HeartMate II 41 RESOLUTE 41 ZYBRESTAT 41 HeartMate XVE 41 VentrAssist 41 BioSTAR R 41 ABSORB trial 41 Pharmacokinetic studies 41 LVAS 41 Cysteamine 41 NTx 41 DAPT 41 Aplidin 41 Proxinium TM 41 NSABP 41 OncoGel 41 selective A1 adenosine 41 BioSTAR TM 41 LAM IPM Wound Gel 41 EVICEL 41 trodusquemine 41 multicenter clinical 41 Healionics 41 UPLYSO 41 MedPulser 41 Inhaled AAT 41 Irinotecan 41 Ketotransdel 41 melphalan prednisone 41 Embolic Protection Device 41 CORD II 41 PROMACTA 41 ProFibrix 41 RESOLUTE clinical 41 vidofludimus 41 TheraCIM 41 DuraHeart LVAS 40 Trinam ® 40 LCP Tacro 40 RhuDex ® 40 RE COVER 40 NanoBio 40 Cypher Stent 40 MYDICAR ® 40 Amikacin Inhale 40 Medidur TM FA 40 heave compensated 40 Kogenate R 40 Stabilimax NZ 40 EXCOR R 40 Oncoscience AG 40 EchoCRT 40 Transplantation BTT 40 BioNumerik 40 PROCHYMAL 40 Trinam 40 Dalbavancin 40 Vital Therapies 40 multicentre randomized controlled 40 XIENCE V stent 40 everolimus eluting stents 40 blind multicenter 40 ADVANCE PD 40 CORD 40 MEND CABG II 40 DU #b 40 Spine Patient Outcomes 40 blind randomized 40 REALIZE 40 multicentre randomized 40 anterior lumbar interbody fusion 40 Teysuno 40 Bexion 40 multikinase inhibitor 40 LCP AtorFen 40 Neovasc Reducer 40 reteplase 40 Medgenics 40 NOX E# 40 PEGylated interferon 40 carboplatin paclitaxel 40 subcutaneously administered 40 Phase 1a 40 STENT 40 NLX P# 40 Percutaneous Transluminal Coronary Angioplasty 40 Onrigin TM 40 ENGAGE AF TIMI 40 CardioFit 40 Dacogen decitabine 40 EOquin TM 40 everolimus 40 BLP# Liposome Vaccine 40 bioabsorbable stent 40 murine monoclonal antibody 40 OLYMPIA registry 40 GW# [003] 40 Oxygent 40 NeoDisc 40 Endurant 40 LCP Tacro TM 40 EDEMA3 40 Litx 40 EVOLVE 40 CZP 40 PFO closure 40 VentrAssist LVAD 40 Ferriprox 40 Turbo Tandem 40 inhaled treprostinil 40 multicenter Phase 40 Tacrolimus 40 blinded placebo controlled 40 placebo controlled clinical 40 M Vax 40 GnRH antagonist 40 Seikagaku Corporation 40 deferoxamine 40 randomized controlled Phase 40 noninferior 39 TMC# [002] 39 ARG# 39 azilsartan medoxomil 39 AmpliMed 39 PROTEGE 39 STAR Ankle 39 Aurora Kinase 39 Phase III randomized 39 TORO 39 comparator arm 39 Medidur FA 39 prospective randomized multicenter 39 AMD# [003] 39 immunotherapeutic vaccine 39 uremic pruritus 39 HTN 39 ENDEAVOR IV 39 Aptivus ® 39 Novacor 39 Archexin 39 Novacor II 39 prospective randomized 39 drug eluting stent DES 39 Impella 39 bifurcated stent 39 prospective multicenter randomized 39 Myeloid 39 orally dosed 39 anecortave acetate 39 bardoxolone 39 randomized #:# 39 Phase IIIb clinical 39 Facet Solutions 39 octreotide implant 39 Parathyroid Hormone 39 MoxDuo 39 Occluded 39 #:# randomization 39 randomized Phase IIb 39 somatostatin analog 39 TAXOTERE R 39 plerixafor 39 Vascugel ® 39 CIMZIA ™ 39 Cloretazine R VNP#M 39 Atrasentan 39 Phase #/#a 39 Kahalalide F 39 YONDELIS 39 CROSSER 39 Stabilimax 39 RHUCIN 39 Zilver PTX stent 39 EVEREST II 39 vasculopathy 39 SYN# 39 Gentamicin Surgical Implant 39 TMC# C# 39 Eluting Stent 39 randomized #:#:# 39 Resten NG 39 G CSF 39 eluting stent 39 TRO# 39 BrachySil TM 39 Melphalan 39 oncolytic vaccine 39 Fracture Intervention Trial 39 Luteinizing Hormone Releasing Hormone 39 unresectable HCC 39 Pivotal Trial 39 NCIC CTG 39 Virulizin R 39 MyoCell 39 Edoxaban 39 VBLOC 39 somatostatin analogue 39 transoral 39 CentriMag 39 RELIANT Trial 39 Sonatherm 39 TAXUS Liberté stent 39 RenalGuard System TM 39 CALGB 39 Phase IIIb 39 CureVac 39 celgosivir 39 XYOTAX TM 39 Cinacalcet HCl 39 sunitinib malate 39 VBLOC Therapy 39 HuMax EGFr 39 Brinavess 39 mSEPT9 biomarker 39 GSK# [001] 39 Theralase 39 BST CarGel 39 PARTNER Trial 39 Phase #b/#a clinical 39 paclitaxel carboplatin 39 ROCKET AF 39 Percutaneous Hepatic Perfusion PHP 39 Cethrin 39 Intravitreal 39 TAXUS Liberte 39 Angioblast 39 HeartMate 39 docetaxel cisplatin 39 relapsing multiple sclerosis 39 multicenter randomized clinical 39 Phase 2b kidney transplant 39 TFAS 39 Hadasit 39 LH RH 39 Vernakalant 39 Mipomersen 39 mineralocorticoid receptor 39 Refractory Angina 39 Advanced Heart Failure 39 MoxDuo IR 39 cetrorelix 39 ORBIT 39 multicentre randomized double 39 WATCHMAN 39 Fabry Disease 39 selective androgen receptor modulator 39 cartilage regeneration 39 OZURDEX ® 39 platelet inhibitor 39 confirmatory Phase III 39 Mpex 39 PFO migraine 39 placebo controlled Phase III 39 Recurrent Glioblastoma 39 fenretinide 39 dacetuzumab 39 monoclonal anti 39 NovoSeven ® 39 comparator PI r 39 Acute Decompensated Heart Failure 39 Talactoferrin 39 INGAP 39 ONTARGET 39 Stephen Huhn 39 stated Michelle Berrey 39 Convivia TM 39 oral ridaforolimus 39 double blinded placebo 39 SIR Spheres 39 Prospective Randomized 39 Fontan procedure 39 Olerup SSP 39 Vertos 39 ADAGIO study 39 IABP 39 Granulocyte Colony Stimulating Factor 39 Demineralized Bone Matrix 39 Interbody Fusion 38 StemEx R 38 Amphinex ® 38 Pradefovir 38 drug eluting balloons 38 TAXUS TM 38 Diamyd R 38 Phase III psoriasis 38 Interventional Spine 38 bevacizumab Avastin ® 38 ibandronate 38 ThermoDox ® 38 Arimidex Tamoxifen Alone 38 Phase 2b study 38 DAVANAT R 38 Collategene 38 Neurostep 38 ELONVA 38 RTOG 38 DNage 38 INT# [002] 38 Novelos 38 Allovectin 7 38 Mersana 38 Randomised 38 NN# [001] 38 Vascular Wrap 38 Ischemia 38 PROMUS Element Stent 38 PPWU 38 preclinical efficacy 38 CoAxia 38 NCT# ClinicalTrials.gov 38 Quinamed 38 multicenter Phase II 38 NeuroVive 38 Bendamustine 38 Angiox R 38 Muscle Pattern Recognition MPR 38 ONTARGET R 38 peptide receptor 38 orally administered inhibitor 38 NO# [002] 38 MYTHOS trial 38 IMPACT DCM clinical 38 juvenile chondrocytes 38 Plasmin 38 Multicenter 38 ATAP 38 PTH analogue 38 generation rotary VAD 38 LT NS# 38 vastus lateralis 38 Celsion 38 REGEN trial 38 Luveniq 38 Paradis Vaso Shield 38 Tavocept 38 insulin detemir 38 Phase 1b clinical 38 pegylated liposomal doxorubicin 38 ART# 38 liver transplant recipients 38 edoxaban 38 Blinatumomab 38 PrevOnco 38 laparoscopic radical nephrectomy 38 Aeroquin 38 PediaFlow VAD 38 FVIIa 38 MVax 38 rFVIIIFc 38 Medinet 38 SoloVir TM ETS 38 EXCITE 38 CorPath 38 Factor VIIa 38 Delcath Phase III 38 RELIANT 38 multicenter randomized Phase 38 CERE 38 paclitaxel stent 38 Self Expanding Stent 38 biventricular 38 XIENCE 38 TAXUS Stent 38 Nonclinical 38 ILUVIEN 38 Dose Ranging Study 38 VESTASYNC 38 Genous 38 MyoCath 38 Phase Ib study 38 HORIZONS AMI trial 38 PROPEL 38 multicenter phase 38 PREZISTA ritonavir 38 ASSERT 38 docetaxel Taxotere ® 38 acute ischemic stroke 38 OrthoGlide 38 STOP AF 38 laquinimod 38 FVT 38 Phase IIa Evidence 38 Elitek 38 sirolimus eluting stents 38 Stemedica 38 Kamada AAT 38 IMC A# 38 DUROS 38 Calmare Therapy Treatment 38 FOLFIRI chemotherapy 38 Harry Palmin President 38 Natural Orifice Surgery 38 Orqis Medical 38 Mycophenolate Mofetil 38 Bellicum 38 KRN# 38 Micromet BiTE 38 Multicenter Automatic Defibrillator Implantation 38 Myoblast Program 38 ZACTIMA 38 HALO# [002] 38 Glybera R 38 TITAN Modular Total 38 Zemplar Capsules 38 Convivia 38 E1 INT TM 38 Cx# [002] 38 TQT 38 selective antagonist 38 dabigatran etexilate 38 Occluder 38 Pitavastatin 38 Proneuron 38 Ophthotech 38 pentostatin 38 capecitabine Xeloda 38 SUCCEED trial 38 beta 1a 38 Angio Seal 38 CINTREDEKIN BESUDOTOX 38 peripheral arterial 38 BAY #-# 38 VBAS 38 dose escalation Phase 38 pharmacodynamic PD 38 AOP Orphan 38 Dabigatran etexilate 38 IV Busulfex 38 Sym# 38 selective A2A adenosine receptor 38 Carotid 38 PF # [001] 38 GLPG# 38 HeartMate R 38 fallopian tube cancers 38 Victhom 38 liposomal formulation 38 ABSORB clinical 38 pharmacokinetic PK study 38 CA4P 38 Mimpara 38 synthetic retinoid 38 WRAIR 38 intravenous dosing 38 saphenous vein grafts 38 Urocidin 38 LifeChoice 38 embolic protection 38 SERCA2a 38 intra articular injection 38 Intec Pharma 38 ERATO 38 Myelodysplastic Syndrome MDS 38 Phase lll 38 ARIKACE 38 HepDirect prodrug 38 Keryx Biopharma 38 EASE Trial 38 Phase III Psoriasis 38 ORBIT II 38 AFRS TM 38 HuMax 38 StromaCel 38 phase IIIb 38 recurrent malignant gliomas 38 Phase III 38 MYDICAR 38 RAV# 38 ZYBRESTAT fosbretabulin 38 INTEGRA 38 QRX 38 paclitaxel poliglumex 38 Viralytics 38 Arcion 38 FOCALIN XR 38 CHAMPION PCI 38 REVEAL Registry 38 MEPACT 38 Septin9 biomarker 38 ZFP TF 38 Zyclara 38 Hsp# Inhibitor 38 Nippon Shinyaku 38 GORE TAG Device 38 regorafenib 38 Multaq R 38 IRESSA 38 nimotuzumab 38 PPAR gamma agonist 38 Terumo Heart 38 TransMID 38 FOR FURTHER INFORMATION ABOUT 38 Endeavor drug eluting 38 solithromycin 38 Increlex R 38 Nanobody 38 Feasibility Trial 38 Allovectin 7 ® 38 Gabapentin GR 38 Cotara 38 DiabeCell ® 38 ORMD 38 NESS H# 38 Liprostin 38 AEGR 38 Phase IIA 38 Liposomal 38 AGGRASTAT ® 38 Hospital Clínic 38 Teflaro 38 Dysport ^ 38 Initiated Phase 38 Aplidin R 38 radiolabeled 38 multicenter randomized double 38 intravenous AAT 38 Atugen 38 sargramostim 37 PREOS R 37 cathepsin K inhibitor 37 FluoroPharma 37 Aflibercept 37 CIMYM 37 Long Lesion 37 BAL# [002] 37 Radiofrequency Ablation RFA 37 INBONE 37 Resten MP 37 MACI 37 KeyNeurotek 37 Endarterectomy 37 TRX1 37 targeted muscle reinnervation 37 BCIRG 37 injectable collagenase 37 TREANDA 37 Arno Therapeutics 37 Catheter Ablation 37 Zilver PTX 37 Lixivaptan 37 Fenretinide 37 TM Vascular Closure 37 Trovax 37 transapical 37 RE LY ® 37 Inclinix 37 CRRT 37 NTx R 37 RARP 37 Endovenous 37 factor VIIa 37 cleavable linker 37 Functional Electrical Stimulation 37 Pivotal Phase II 37 DEB# 37 CF# [002] 37 placebo controlled randomized 37 ExCell study 37 LPV r 37 Arthroplasty 37 REALITY Trial 37 PDE4 inhibitor 37 Resolute DES 37 metastatic renal cell carcinoma 37 Nipent R 37 miglustat 37 ThermoDox R 37 Aposense 37 Scancell 37 SonoPrep 37 lorcaserin Phase 37 Bayer Onyx 37 administered subcutaneously 37 KAHR Medical 37 CCX# B 37 Xerecept 37 BARACLUDE r 37 CK # administered 37 HSP# inhibitor 37 HeartWare HVAD 37 Neupogen ® 37 treatment naive genotype 37 VIR# 37 TAXUS Element Paclitaxel Eluting 37 imiglucerase 37 difluprednate 37 HCD# [002] 37 OMP #M# 37 Medtronic CoreValve ® 37 Symadex 37 Fibrillex TM 37 AZD 37 XIENCE V Everolimus Eluting 37 Ceflatonin R 37 daily subcutaneous injections 37 GeneICE 37 KYTHERA 37 tipranavir 37 Onconase 37 Annexin V 37 neoadjuvant 37 Phase #b/#a 37 Subcutaneous 37 Biopump 37 Alvesco R 37 SpineAlign 37 topically administered 37 abiraterone acetate 37 RPL# 37 ELIQUIS 37 IMPACT DCM trial 37 Leukine ® 37 MD FACS FAAP 37 anti CD3 37 Genz # 37 Phase 2a preventative 37 Zerenex 37 DB# [003] 37 PROTECT AF 37 Heart Transplantation 37 Phase IIa trials 37 darunavir r 37 synthetic anthracycline 37 Phase III confirmatory 37 CBLC# 37 System LVAS 37 Edwards SAPIEN valve 37 eplerenone 37 anti muscarinic 37 cortical stimulation 37 occluders 37 BRIM2 37 fully bioabsorbable 37 Alagebrium 37 Genzyme Synvisc 37 Cell Pouch System 37 GEM OS2 37 RCT 37 Cethromycin 37 Catena ® 37 DAIICHI SANKYO 37 Phase Ib 37 Cytochrome P# 37 DAVANAT ® 37 Phase Ib II 37 XIENCE V PROMUS Stent 37 Xelox 37 lorvotuzumab mertansine 37 OMS# 37 Ostarine 37 Aortic Valve 37 NOSCAR 37 subconjunctival injection 37 DIABECELL 37 rFactor XIII 37 PediaFlow 37 Pyng Medical 37 metastatic RCC 37 Amrubicin 37 Metricath Gemini 37 Teijin Pharma 37 sitagliptin phosphate 37 blinded randomized 37 Vancocin ® 37 Dual Opioid 37 RLY# 37 MIV 37 fluoropyrimidine 37 dose escalation phase 37 Lucanix 37 DEEP AF 37 CIPN 37 Aneurysm Repair 37 Medtronic CoreValve 37 inhaled AAT 37 Abbokinase 37 direct thrombin inhibitors 37 PediGuard 37 Combo Stent 37 Spheramine 37 XIAFLEX 37 allogenic 37 acute PAO 37 Cardio Assist 37 vascular disrupting agent 37 zalutumumab 37 Nexavar ® 37 multicenter randomized placebo controlled 37 Novacor R 37 Davide Gozzini ITA 37 Andara ™ 37 thrombus aspiration 37 multicenter 37 HuMax CD4 37 PMED 37 rilpivirine 37 mitomycin 37 iFuse Implant System 37 Raptiva r 37 Neurologix gene 37 ProMune 37 Tolerability Study 37 Carticept 37 Thrombin 37 collagenase 37 renin angiotensin aldosterone 37 REFLEX 37 KN# [001] 37 thyroid hormone receptor 37 recurrent malignant glioma 37 Tissue Genesis 37 AIR CF1 37 Alethia Biotherapeutics 37 locoregional disease 37 TG# [001] 37 dose escalation clinical 37 NKTI 37 administered intradermally 37 multicenter dose escalation 37 AQ4N 37 randomizing patients 37 randomized clinical 37 drug eluting coronary stent 37 intra arterial 37 Current Controlled Trials 37 humanised monoclonal antibody 37 Xpert HemosIL FII 37 NMES 37 saphenous vein graft 37 EOquin 37 VPRIV 37 Xyfid 37 AGGRASTAT R tirofiban hydrochloride 37 MKC# MKC# PP 37 SpideRX 37 BioMatrix 37 Ablation System 37 myoblast therapy 37 randomized multicenter 37 Onconova 37 VIAject ® 37 Traficet EN 37 Rheos 37 Fabio Holanda 37 TroVax ® 37 Proxinium 37 BIO SET 37 Acute Coronary Syndromes ACS 37 immunomodulatory therapy 37 glucokinase activator 37 BrainGate 37 Sibutramine Cardiovascular Outcomes 37 FJORD 37 PROCRIT R 37 AOD# [002] 37 prospective nonrandomized 37 phase Ib 37 GRN# 37 proteasome inhibitor bortezomib 37 thorough QTc 37 BST CarGel R 37 Febuxostat 37 Glufosfamide 37 Gliadel Wafer 37 SUPERA stent 37 Fluconazole 37 chemoradiation therapy 37 tesmilifene 37 Akt inhibitor 37 MICARDIS ® 37 ADP receptor antagonist 37 Phase III pivotal 37 controlled multicenter Phase 37 pro angiogenic 37 Curacyte AG 37 piperacillin tazobactam 37 ceftazidime 37 ACTIVE W 37 Ventaira 37 steroid refractory 37 pain palliation 37 antibody MAb 37 chimeric monoclonal antibody 37 CGRP 37 rADTZ 37 Sanvar 37 trastuzumab Herceptin R 37 BCNS 37 BRILINTA 37 Troxatyl 37 ISTODAX ® 37 Cloretazine 37 Simulect 37 double blinded randomized 37 subcutaneous immunoglobulin 37 randomized discontinuation 37 Can Fite 37 Acute Ischemic Stroke 37 cariprazine 37 lanreotide 37 Ceplene/IL-2 37 SUTENT ® 37 BioControl 37 LB# [003] 37 pharmacodynamic profile 37 ATL/TV# 37 multicenter clinical trials 37 Annuloplasty 37 nab paclitaxel 37 Sirolimus eluting 37 valopicitabine NM# 37 MWT 37 clevidipine 37 canakinumab 37 TASQ 37 RIGS 37 II Clinical Trial 37 confirmatory Phase 37 Cardiosonix 37 MIST Therapy 37 Symplicity Catheter System 37 SparVax TM 37 GetGoal Phase III 37 Juventas 37 DP b# 37 MEND CABG 37 TCT 37 Vascugel 37 selective orally bioavailable 37 Prima BioMed 37 Asubio Pharma 37 romidepsin 37 Kogenate FS 37 acute tubular necrosis 37 Left Atrial Appendage 37 Bradmer 37 ELACYT 37 XIENCE TM 37 VALOR 37 HYLENEX recombinant 37 Solesta 37 voclosporin 37 Investigational Device Exemption IDE 37 AIR2 Trial 37 Multimeric 37 IFN α 37 Intramuscular 37 Cardiac Dimensions 37 CryoPlasty 37 HepatAssist 37 APTIVUS 37 randomized Phase III 37 AP# [003] 37 hereditary deficiency 37 SPEAR 37 RHEO 37 novel oral anticoagulant 37 methylnaltrexone 37 budesonide MMX ® 37 ZYTIGA 37 paricalcitol 37 DDW 37 IAP inhibitor 37 Biotecnol 37 CCX# 37 Lucentis ranibizumab Genentech 37 HDACi 37 diclofenac sodium 37 ritonavir boosted 37 Angiotech Pharma 37 DMD DMSc 37 Angiocept 37 nanoemulsion 37 HeartMate ® 37 Urodynamix 37 pegylated liposomal doxorubicin PLD 37 HuMax CD# 37 Anticalin R 37 Lixte 37 SIMPADICO 37 TroVax 37 Autologous 37 receptor tyrosine kinase inhibitor 37 amrubicin 37 ReN# 37 Phase III metastatic melanoma 37 intravenously administered 37 viral kinetic 36 Xcelerant Delivery System 36 humanized monoclonal 36 mapatumumab 36 MAKOplasty procedures performed 36 Granted Orphan Drug 36 Ophena 36 Palmaz stent 36 Optivia 36 catheter occlusion 36 CSPG 36 analgesic efficacy 36 PRO TOE ™ 36 multicentre 36 LANTUS ® 36 MolMed 36 CLL SLL 36 EQUIP OB 36 darunavir ritonavir 36 BioOncology 36 Long Term Efficacy 36 Emboshield 36 Zor Pharmaceuticals 36 IFN alfa 36 internal thoracic artery 36 Capesaris 36 Xanafide 36 SGLT2 inhibitor 36 CryoValve SG 36 Genomatix 36 Recombinant Human 36 PrevOnco ™ 36 Oxycyte 36 Zirgan 36 ASCT 36 Stenting Trial 36 pharmacokinetics PK 36 myoblast 36 Circulatory Support 36 Ascendra 36 GHRH 36 Chemophase 36 EndoTAG TM -1 36 AZOR 36 pegylated recombinant 36 Biotec Pharmacon ASA 36 Taxus Liberté 36 GlucoLight 36 Phase III randomized controlled 36 Initiate Phase 36 Anavex #-# 36 coflex 36 Immunotherapeutic 36 CALGB # [002] 36 cells mcL 36 Severe Sepsis